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ABSTRACT
Controlled substance abuse is a common problem in the United States. While the
number of controlled substance deaths or injuries is increasing, the number of controlled
substance prescriptions is increasing as well. Many providers acknowledge controlled
substance abuse as a problem in the United States, but it is unknown how often these
providers are taking measures to prevent abuse of prescribed controlled substances.
Although all controlled substances are not acquired by legal prescriptions, many are. The
aim of the study was to ascertain whether nurse practitioners in Mississippi are using the
prescription monitoring program (PMP) to assist in creating a reduction of such
prescriptions and decrease prescription abuse. A quantitative study design was used by
distribution of a survey on social media consisting of 13 questions. Fifty nurse
practitioners completed the survey. The majority of these individuals reported using the
PMP prior to writing prescriptions for controlled substances and basing decisions on
whether or not to continue to prescribe these categories of medications on the information
the PMP provided. The majority reported they are not referring patients for substance
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abuse treatment based upon the findings of the PMP. Most respondents seem to be
utilizing the prescription monitoring program appropriately by responding they utilize the
PMP before prescribing opioids and that using the PMP has reduced the number of
opioids they prescribe. This software appears effective in controlling the amount of such
prescriptions. Substance abusers usually need treatment to assist them in ceasing use of
controlled substances, and it seems that nurse practitioners in Mississippi may not be
adequately acknowledging or referring these patients.

Keywords: prescription monitoring program, controlled substance, opioid
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Mississippi Nurse Practitioners' Utilization of Prescription Monitoring Program and the
Reduction of Controlled Substances
CHAPTER I
Introduction

Opioid overdose deaths have dramatically increased in the past three decades and
continue to rise. The opioid crisis is taking the lives of 115 people every day. A recordbreaking 33,000 people died as a result of opioids in 2015. Alarmingly, an estimated half
of all opioid overdose deaths involved a prescription opioid (Mississippi State
Department of Health. 2016). As of 2016, the number of opioid deaths was five times
higher than in 1991. Aggressive prescribing practices play the biggest role in this
devastating spiral that has precipitated the opioid epidemic. Between 1999 and 2014,
opioid prescriptions tripled from 76 million to 219 million per year (Rudd, Seth, David,
& Scholl, 2016). Prescription rates for opioids in the United States are 40 percent higher
than the rate in other countries. The Centers for Disease Control and Prevention (CDC)
estimates that the total economic burden of prescription opioid misuse in the United
States is over $78 billion USD per year (CDC, 2018).
Prescription opioids can be used to treat moderate-to-severe pain. Consuming
opioids for increased periods of time or in higher doses correlates with the increased risk
of addiction, overdose, and death. The most common drugs involved in prescription
opioid overdose deaths include Methadone, Oxycodone, and Hydrocodone (CDC, 2018).
Healthcare providers began using opioids in the late 1990s, and distribution has
continued to grow. Research suggests this is due to pharmaceutical companies marketing
opioids without disclosing possible concerns associated with their consumption. As
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prescribing continued, more opioid prescriptions were written for more days per
prescription and in higher doses (CDC, 2018).
Southeastern U.S. states, including Mississippi, have the most prescriptions per
person for opioid painkillers. Furthermore, Mississippi's rate of opioid prescriptions is
one of the highest in the nation (Mississippi State Department of Health, 2016).
Mississippi recently mandated that nurse practitioners must access and monitor the
Prescription Monitoring Program. In 2017, over 3 million opioid prescriptions were
dispensed in Mississippi. The rate of opioid prescriptions per 100 persons was enough
for each person in the state to have one opioid prescription drug during 2017 (Mississippi
Prescription Monitoring Program).
The CDC is committed to implementing guidelines that will prevent opioid
overdose. These guidelines include improving opioid prescribing, reducing exposure to
opioids, preventing misuse, and treating opioid use disorder (CDC, 2018). Furthermore,
the United States passed legislation to decrease high-risk prescribing practices through
the Prescription Monitoring Program (PMP). A prescription monitoring program is an
electronic database that tracks controlled substance prescriptions in a state (CDC, 2018).
The Mississippi Prescription Monitoring Program is managed by the Mississippi Board
of Pharmacy to aid practitioners and dispensers in providing proper pharmaceutical care
related to controlled substances. Clinical practice guidelines encourage use of the PMP
prior to prescribing to assess a patient's history of controlled substance use. The aim of
this program is to support the legitimate use of controlled substances in addition to
safeguarding public health and safety (MSDH, 2016).
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In order to reverse the opioid epidemic, improvement is needed in the strategies
used to treat pain. Prevention of abuse, addiction, and overdose are key factors. For the
purpose of this research, a focus was placed on the following: (a) nurse practitioners'
utilization practices of the PMP in the state of Mississippi and (2) opioid prescribing
practices by nurse practitioners in the state of Mississippi. Investigation of these key
elements may highlight areas of Mississippi's opioid prescribing practices that need
improvement.
Purpose of the Research Project
Primary care providers prescribe more controlled substances than any other
provider. Southeastern U.S. states, including Mississippi, have one of the highest opioid
prescription rates in the nation (Mississippi State Department of Health, 2016). This
practice promotes a growing area of concern for care providers and patients in regard to
controlled substance abuse. Opioid overdose deaths have dramatically increased in the
last three decades. In 2017 opioids were involved in 47,600 deaths, which is six times
higher than overdose deaths in 1999 (CDC, 2018). More alarmingly, overdose is
identified as the leading cause of accidental deaths in the United States. Prescription
opioids are involved in nearly half of all opioid overdose deaths (Mississippi State
Department of Health. 2016). Aggressive prescribing practices have been shown to play
a contributing role in the opioid epidemic. Deaths related to opioids are higher in those
that received opioid prescriptions from multiple providers. Improving the way opioids
are prescribed can ensure patients have access to safer treatment, while reducing the
potential for misuse or overdose. Clinical practice guidelines encourage use of the PMP
prior to prescribing in an effort to assess a patient's history of controlled substance use
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(CDC, 2018). 1 he Mississippi Prescription Monitoring Program is an electronic tracking
program to help practitioners and dispensers identify any possible inappropriate use of
controlled substances. The PMP mission is to support the legitimate use of controlled
substances while safeguarding public health and safety. The purpose of this study was to
determine whether nurse practitioners in the State of Mississippi are utilizing the PMP
appropriately, in order to reduce controlled substance abuse and ultimately save lives.
Significance of the Research
This study will be beneficial to practitioners and state agencies in determining
best practices for PMP use for the monitoring of controlled substance abuse and risk
reduction. If lack of compliance of practitioners is determined, measures can be
developed to improve adherence to state guidelines. According to the Mississippi Board
of Pharmacy in 2017 there were 823,133 Mississippians who filled an opioid prescription
(Mississippi Board of Pharmacy, 2018). The research was significant to primary care
nurse practitioners, because they see many patients who either have a history of
controlled substance prescriptions or are currently using controlled substances. Some
patients may be using these appropriately, while others may not. It is the responsibility of
nurse practitioners with prescriptive authority to monitor the prescription monitoring
program and make clinical decisions based upon the findings of this data. Primary care
nurse practitioners treat patients with a wide variety of conditions that may require
controlled substance prescriptions such as pain and anxiety.
The research is also significant for overall health outcomes for patients. Increased
awareness by the provider of the patient's use of controlled substance prescriptions
hopefully will lead to more assertive care when prescribing of such medications.
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Subsequently, patient health outcomes can be improved with use of alternate medications
or treatment modalities, such as psychiatric therapy and physical therapy, instead of
controlled substances. Diligent use of the prescription monitoring program can improve
health outcomes for patients and detect the potential of misuse of controlled substances.
Promoting responsible controlled substance prescribing among nurse practitioners
in primary care is essential in promoting health of patients that can potentially be
adversely affected by controlled substances/opioids. Opioids were responsible for deaths
of over 33,000 people nationally in the year 2015. Approximately half of those deceased
had a valid prescription for the opioid which resulted in their demise (Mississippi State
Department of Health. 2017). The number of controlled substance abuse and
subsequently fatalities is clearly rising. Promoting stewardship of such prescriptions is
crucial to promoting health in our community and nation.
Conceptual Framework
Dr. Nola Pender's Health Promotion Model (2006) was used to guide this study.
This model is appropriate because it emphasizes the importance of identifying health
behaviors among all age groups and seeks to intervene in ways that promote health of the
individual. It focuses on factors believed to influence change in a wide array of health
behaviors. Pender asserts that patients and providers will be more likely to engage in a
specified behavior if they perceive benefits from the behavior. For our research, the
concept of perceived benefits of primary care providers checking PMPs prior to
prescribing controlled substances was examined.
Nola Pender's nursing model focuses on health promotion. She did not define
health as simply the absence of disease, rather she wanted to focus on "increasing a
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patient's level of well-being" (Petiprin. 2106. p. 1). Pender's model is important to
nursing because nurse practitioners may be the primary care provider for the patient and
possibly the only person in authority that could influence a patient to seek health
promoting activities and behaviors.
Pender and Pender (1980) completed a research study to determine nurse
practitioner interest in health promotion, as well as the interest of patients in participation
within health promotion. Pender stated. "Nurse practitioners as key health clinicians
have a major responsibility for developing innovative prevention and health promotion
programs" (Pender & Pender, 1980, p. 798). Through their study, Pender and Pender
found that if a community offered health promotion and preventative services by a nurse
practitioner, most of the surveyed patients responded they would be willing to participate
in such services. This research provides a perspective from Pender that expressed her
belief that health promotion by nurse practitioners was strongly needed, enough so to
dedicate many years to the research and promotion of this idea. As such, the Pender
Health Promotion Model was also applicable to our research topic, as reduction of
controlled substances is a pressing health promotion issue in need of intervention.
Nursing curriculum also has the potential to be positively influenced by our
research. Graduate nurses are learning how to become advanced practice nurses, many of
whom may become nurse practitioners with prescriptive authority. The opioid epidemic
is a well-known problem in American society. A nurse practitioner and prescriber need to
be educated on the risks and benefits of prescribing controlled substances. Many
graduate nursing students are unfamiliar with the Mississippi prescription monitoring
program and will not understand the importance of it without proper education.
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Currently, many advanced practice nurses may be introduced to the prescription
monitoring program post-graduation as they begin clinical practice. However, this
research has the potential to influence accredited nursing programs on the benefit of
educating students on the use of the prescription monitoring program. Therefore,
graduate healthcare providers can benefit from having the prior knowledge and exposure
of the Mississippi prescription monitoring program as they begin practicing.
Research Questions
Two research questions were formulated which the researchers desire answered:
1. Do primary care providers in Mississippi utilize the prescription monitoring
program for patients before prescribing or refilling controlled substances?
2. Has use of the prescription monitoring program reduced the number of
prescriptions for controlled substances that primary care providers prescribe?
Definition of Terms
For this study, there were several terms that need to be defined as they apply to
the study. The theoretical and operational definitions are defined as follows.
Primary care providers.

Theoretical. A primary care provider (PCP) is a health care practitioner who sees
people that have common medical problems. (Vorvick, 2016)

Operational. Licensed nurse practitioners in the State of Mississippi who
prescribe medications to patients. (Mississippi Board of Nursing)
Prescription Monitoring Program (PMP).

Theoretical. Prescription Monitoring Programs (PMPs) are highly effective tools
utilized by government officials for reducing prescription drug abuse and diversion.
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PMPs collect, monitor, and analyze electronically transmitted prescribing and dispensing
data submitted by pharmacies and dispensing practitioners. (PDMP TTAC)

Operational. The Mississippi Prescription Monitoring Program (PMP) is an
electronic tracking program managed by the Mississippi Board of Pharmacy to aid
practitioners and dispensers in providing proper pharmaceutical care relating to
controlled substances. (MS PMP)
Patients.

Theoretical. An individual who is under or awaiting medical treatment or care
(Merriam-Webster).

Operational. Individuals who are under a nurse practitioner's medical care.
Controlled substances.

Theoretical. "A substance (as a drug) whose use and possession is regulated by
law (as title 21, chapter 13 of the U.S. Code)" (Merriam-Webster).

Operational. Prescriptions written for medications defined as Schedule II-V by
United States Drug Enforcement Administration.
Prescription

Theoretical. A written direction for a therapeutic or corrective agent, specifically,
one for the preparation and use of a medicine (Merriam-Webster).

Operational. Medication requiring a written or electronic order from a medical
provider that must be obtained from a pharmacy counter.
Assumptions
For the purpose of this study, the following assumptions were made:
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1.

I he researchers assumed that nurse practitioners in the state of Mississippi are
following CDC guidelines when prescribing opioids.

2.

I he researchers assumed the number of controlled substance prescriptions
written by Mississippi nurse practitioners will decrease due to usage of the
PMP.

3. The researchers assumed that a decrease in the number of opioid related
overdoses and deaths will result from adherence to the CDC guidelines by
Mississippi nurse practitioners.
4. The researchers assumed that nurse practitioners in Mississippi were more
likely to comply with CDC guidelines if there was a perceived benefit of the
PMP system.
The researchers assumed that data from a questionnaire would be an efficient and
comprehensible way to obtain required data. It was assumed that data would be collected
in a logical and ethical manner. It was also assumed that the Survey Monkey website
would accurately compute the survey data. An additional assumption was that the nurse
practitioners were answering the survey questions honestly. Lastly, it was assumed that
the data would be correctly interpreted by the research team. The assumptions held by
the researchers had the potential to affect the survey results significantly should these
assumptions have been false.

CHAPTER II
Review of Literature
Primary care providers prescribed more opioids than any other providers in the
state ot Mississippi, making them one of the highest to prescribe in the nation
(Mississippi State Department of Health, 2016). The CDC (2016) recommended review
ot the PMP in conjunction with prescribing or refilling controlled substances. Literature
was reviewed to determine utilization of the PMP by primary care nurse practitioners and
the possible outcome ot reduction of controlled substance prescriptions. We reviewed
research articles that supported the completion of our study. The articles reviewed
contained data that was useful to our research, because the researchers examined similar
questions or topics. We also reviewed literature where the researchers utilized the Health
Promotion Model of Nola Pender, and we found this model be an appropriate nursing
theory to utilize for our research study. The review of literature provided information to
guide our research and identified other areas of possible future research.
Health Promotion Model
Bradbury-Golas (2013) based her research study on Nola Pender's revised health
promotion model. This model promotes self-efficacy and shows the correlation between
self-efficacy and increased positive outcomes on health and wellness. Bradbury-Golas
(2013) performed a research study to compare the health promoting practices of
recovered opiate-dependent drug users and those of relapsed opiate-dependent drug users.
Opioid abuse and dependence by Americans has been increasing in prevalence every
year. This dependence causes decreased wellness of the user and affects others who have
a significant relationship with the user. Overall healthcare costs have been greatly
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affected by health outcomes of opioid users. Opioid users had increased instances of
comorbidities due to side effects and lack of personal concern for health. Opioid abusers
were shown to have greater recovery and maintenance of recovery when they had access
to more education and resources.
Bradbury-Golas (2013) proposed two research questions for her study. The first
question was, "What are the health promotion practices of recovering opiate-dependent
drug users? (p. 476). 1 he second question was. "What are the differences between these
health promotion practices and those of abusing opiate-dependent drug users?" (p.477).
1 he results of the study revealed that health promoting behaviors were significantly
higher among recovered opiate-dependent users (average HPLP score 2.78) than those of
current opiate-dependent users (average HPLP score 1.85). The study also compared
health characteristics, such as smoking status, current health perception, use of other
drugs, and weight loss or gain of 15 pounds over the last year. In all responses recovered
opiate-dependent users had more positive health promotion characteristics than those of
current opiate-dependent users.
Bradbury-Golas (2013) compared these findings to other studies regarding health
promotion among other vulnerable populations and found that other vulnerable
populations had similar health promotion behaviors and perceptions. Bradbury-Golas
(2013) also identified that less funding was available for recovery treatment facilities and
that insurers have adapted reimbursement programs to allow for more treatment of
opiate-dependent abusers and recovering or recovered opiate-dependent abusers by
primary care practitioners. More research needs to be done to establish the efficacy of
the role of primary care practitioners in the management of opiate-dependent abusers,
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especially in the educational training ot the provider and the clinic practice in health
promotion among that population of patients.
Bradbury-Golas (2013) found the improved outcomes of opiate-dependent
abusers to the instruction ol health promotion that was received through recovery
counseling. I his outcome was applicable to the research of use of Prescription
Monitoring Programs (PMP) and the reduction of opioid abuse. Bradbury-Golas (2013)
indicated that providers who used the PMP could take advantage of the findings on the
PMP and create an opportunity to screen patients for risky behaviors. By screening
patients for risky behaviors, providers could identify the need for further counseling and
education of patients which in turn could promote a healthier lifestyle for patients.
PMP Design and Function
Rutkow, Smith, Lai, Vernick, Davis, and Alexander (2017) conducted a qualitative
study in four purposefully chosen states to attempt to gain an understanding of how the
49 states have implemented prescription monitoring programs. They also sought to learn
more regarding the attitudes and experiences based upon PMP usage among providers.
Also, they wanted to "present common themes within and across states, and then discuss
how our findings might assist states seeking to improve the effectiveness and costeffectiveness of their PMPs" (Rutkow et al., 2017. p. 395). The background of their
study focused on the challenges that our public healthcare system in the United States
faced related to opioid-related overdose deaths. The article discussed how several studies
have already been done, which acknowledged that prescriber utilization of PMPs was
hindered by many various reasons. This study sought to gain insight into the problem of
implementation of PMPs by individual state governments as well as their individual state

goals of PMPs and "How a PMP's characteristics may facilitate or hinder the
accomplishment of these goals" (Rutkow et ah, 2017, p. 396). The article was based
upon multiple data sources of prior articles that found PMP data, although useful, to be
cumbersome. Rutkow et al. (2017) felt that prior studies defined obstacles to utilization
of prescription monitoring programs but did not elaborate on the implementation or the
various stakeholders' views of the goals of PMP.
Rutkow et al. (2017) sought to determine what the key prescription monitoring
program goals in selected states were when implementing PMPs. They also wanted to
know how a PMP's characteristics aided in the completion of the goals for their state.
This study by Rutkow et al. (2017) was conducted from May 2015 to June 2016
utilizing interviews with 37 various stakeholders within four specifically chosen states to
give a somewhat accurate representation of the entire United States. The states chosen
were Florida, New Jersey, Kentucky, and Ohio; these were specifically chosen due to
various PMP infrastructures in these states.
The statistical findings of the study included identification by interviewees of 4
main goals of PMPs within their states: "1) Improve providers' patient treatment
decisions, 2) Influence prescribing practices, 3) Assist in the identification of "doctor
shoppers", and 4) Serve as a tool for law enforcement" (Rutkow et al., 2017, p. 397).
Most of the interviewees recognized benefit to healthcare providers as being the main
goal or priority of prescription monitoring programs. Collaborative efforts of healthcare
and law enforcement regarding use of the PMP were a shared focal point for many
interviewees. Interest concerning collaboration would hopefully help establish goals of
improving the opioid epidemic. Based upon the research findings, the researchers felt

14

that. "To increase PMP effectiveness, states should consider opportunities to improve
prescribers knowledge and familiarity with these databases and to ensure that PMP data
are appropriately used" (Rutkow et ah, 2017, p. 397). Interviewees reported that one key
improvement in PMPs that could likely improve utilization by healthcare providers,
included interfacing monitoring programs into electronic medical records in order to
improve ease of access. The implications of Rutkow et al.'s (2017) research outcomes to
healthcare were that PMPs could become a much more effective tool to healthcare
providers when used appropriately and offered with simple accessibility.
Reduction of Inappropriate Prescriptions
Dormuth, Miller, fluang, Mamdani, and Juurlink (2012) performed a time series
analysis to research effectiveness of a prescription monitoring network at reducing
inappropriately controlled substance prescriptions. Dormuth et al. (2012) focused their
study on opioid analgesics and benzodiazepines which they stated are "often misused in
clinical practice." (p. 853). Prescriptions that were filled within 7 days of another similar
prescription and those that were written by a different prescriber were the focus of the
study. This study took place in Canada and information regarding the prescriptions was
obtained through PharmaNet, the prescription monitoring network.
Dormuth et al. (2012) studied prescriptions written to citizens over 65 years of
age and citizens that received social assistance for prescriptions. These subjects were
chosen because a non-real time database for tracking these subjects was in place before
the real-time PharmaNet began. The researchers studied data that was collected 30
months prior to the implementation and 30 months after the implementation of
PharmaNet. Data was collected on controlled substance prescriptions filled within 7 days
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of a similar prescription and controlled substance prescriptions written by a different
prescriber within 7 days. The study aimed to show that prescription monitoring networks
were effective in reducing inappropriate prescriptions. Dormuth et al. (2012) calculated
the proportion of change in inappropriate prescriptions before the prescription monitoring
network began and after the prescription monitoring network was implemented and the
result was a 32.8 percent decrease of inappropriate prescriptions for opioids and a 48.6
percent decrease in inappropriate benzodiazepines prescriptions among the study
population during the time frame studied.
Dormuth et al. (2012) also looked at other reported prescriptions, mainly
NSAIDS, to analyze data that might disprove that only prescriptions that are subject to
abuse were reduced. Their cross study did not show a reduction in NSAID prescriptions,
and therefore, the researches summarized that the prescription monitoring network may
not be effective for the reduction of other duplicate drug therapies. However, the study
supports research that prescription monitoring is a highly effective tool for the reduction
of prescription drug abuse.
Prescribing Trends and Utilization of PMP
McCall III, Tu. Lacroix, Holt. Wallace, and Balk (2013) conducted a study to
evaluate prescribing and dispensing trends of the Maine PMP database and to review
utilization patterns of recipients who used multiple prescribers and pharmacies. Opioid
abuse can lead to addiction, overdose, and death. The number of opioid related fatalities
continues to rise throughout the United States. The significance of this study was to help
raise awareness among clinicians, dispensers, and recipients in efforts to improve public
safety and health as well as cost-effectiveness of opioid use.
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McCall et al. (2013) aimed to evaluate two key points. Their interests included
reviewing the Maine PMP database to identify prescribing practices and assessing
potential patterns of prescription drug misuse among recipients who used multiple
prescribers and/or dispensaries. By focusing on these points, they hoped to provide
education for implicated improvements. This four-year study population included
individuals in the state of Maine, who received at least one controlled substance
prescription from a credible pharmacy between the years 2006 and 2010. The researchers
used an epidemiologic analysis of the PMP database.
Following analysis, the controlled substance prescription trends showed an overall
increase in numbers. McCall et al. (2013) found a dispensed total of approximately 11.5
million controlled prescriptions for approximately 1 million patients. Over the four-year
span a significant increase in prescriptions was noted, rising approximately 22% from the
starting year of the study. There was also an increase in the average number of
prescriptions per patient. Of the unduplicated prescribers contributing to this increase,
approximately 75% were out-of-state. In-state prescribers were found to be responsible
for most of the prescriptions. The average number of days of supply for opioids also
increased by about 31%. Furthermore, opioids were found to be the most frequently
prescribed scheduled drug class during this study. Of the physician and pharmacy
utilization practices, approximately 83% of patients obtained their prescriptions from one
or two prescribers. Approximately 94% of individuals used one or two pharmacies in
comparison to several. This conversely exemplified that those who use multiple
providers also use multiple dispensaries. McCall et al. (2013) provided a strong
foundation upon which we can build our research because it identified the critical need
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for the PMP due to the increased prescribing of opioids and "doctor shopping" of the
consumers.

Physician's Experience with PMP
Lin, Lucus, Murimi, Jackson, Baier, Frattaroli, Gielen, Moyo, Simoni-Wastila,
and Alexander (2016) performed a cross-sectional postal survey among primary care
physicians, pain management physicians, and emergency medicine physicians in the state
of Maryland. The purposes of their study were to determine if the PMP impacted
changes in opioid prescribing, to determine PMP utility among prescribers, and to
determine usage banders of the PMP since its implementation in Maryland in 2013.
Lin et al. (2016) sought to evaluate physician attitudes and experiences with
Maryland's prescription monitoring program (PMP). Lin et al. (2016) concluded that
most physicians using Maryland's PMP believed it decreased the amount of opioid
prescriptions written as well as increased physicians comfort level with prescribing
opioids. Lin et al. (2016) also concluded that increased prescriber education was an
essential need for increasing PMP usage. This study was relevant to our research because
the basis of both studies was the impact of PMP on prescribing practices. Similar
variables were being studied, such as primary care physician's utilization of the PMP, and
if the PMP affected the number of controlled substance prescriptions being written. Lin
et al. (2016) used a survey to conduct their research which was also the method used to
conduct our research. The large number of similarities between the survey questions
provided significant state-to-state comparison and provided helpful information for
combating the opioid epidemic faced in America.
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Who Uses a PMP and How
Irvine. Hallvik, Hildebran, Marino. Beran. and Deyo (2014) performed a
statewide survey to identify which type of prescriber utilized the state of Oregon's PMP.
the setting in which they practiced, and any barriers associated with the use of the PMP.
Irvine et al. (2014) poised two research questions to base their study. The first question
addressed the demographics of the prescriber, including clinical setting and the frequency
of use of the PMP in comparison to the volume of patients. The second question
addressed the actions that triggered the prescriber to access the PMP, their reaction to a
concerning PMP report, and the patient's response if the prescriber discussed concerns of
the report with the patient. The purpose of these questions was to determine who
accesses the PMP and what they did with the information they found in the PMP (Irvine
et ah, 2014).
Their research study was conducted by means of a survey. Oregon prescribers
with DEA licenses that were also registered users of the state's PMP were provided a
survey based on their frequency of usage of the PMP. The survey results revealed
physicians and physician assistants accessed the PMP more than other prescribing
providers. More than half of non-users reported prescribing controlled substances
frequently. Psychiatrists had a high rate of prescribing controlled substances and a low
rate of utilization of the PMP. Physicians who had training in chronic pain treatment and
substance abuse reported higher usage rates of the PMP than those who did not have
training. Most prescribers who used the PMP responded they would access it if they
suspected diversion or substance abuse. Most prescribers responded they would discuss
findings on the PMP with the patients if they were suspicious of diversion or substance
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abuse, three quarters of prescribers would use an alternate medication, and more than half
would refer the patient to treatment for substance abuse or mental health disorders. The
prescribers reported that most of the time patients were angered by the physician's
concern of diversion or abuse and most patients did not return to the prescriber for further
treatment. Most registered users responded that more training in management of chronic
pain and substance abuse would make findings of the PMP more useful and make their
reaction and response to PMP findings an easier transition into patient care. Irvin et al.
(2014) indicates routine guidelines for practice would be beneficial for the use of the
PMP in healthcare organizations.
Irvin et al. (2014) addressed one of the research questions for our project. Irvin et
al. (2014) also recommended further studies to address the question of whether use of the
PMP changes the way providers prescribe medications, which correlated to whether or
not use of the PMP reduced the amount of prescriptions for controlled substances that
primary care providers prescribe. Irvin et al. compared outcomes from various of various
prescribers in regard to discussions of controlled substance usage with their patients.
Accessing the PMP
Gershman, Gershman, Fass, and Popovici (2014) mailed questionnaires to a
random sample of 5,000 medical doctors and osteopathic physicians licensed in Florida
from January to June 2013. The purpose of this study was to evaluate Florida physicians'
attitudes and knowledge toward accessing the state's prescription monitoring program.
The authors sought to evaluate Florida physicians' attitudes and knowledge toward
accessing the state's PMP.
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Gershman et al. (2014) examined Florida providers that have access to the PMP,
providers that are in progress of obtaining access, and providers that do not have access.
71.5% of participants agreed or strongly agreed that the PMP was a useful tool for
monitoring a patient's controlled-substance history. Seventy-two and a half percent of
participants agreed that "doctor shopping" would decrease if patients were aware that
physicians were utilizing the PMP to check their prescription history, and therefore, they
would not be able to get another controlled substance prescription. Among 64 most
frequent PMP users, 69.4% agreed or strongly agreed after accessing the PMP they
prescribed fewer controlled substances. Among nine physicians in a pain management
specialty, 12.5% agreed or strongly agreed that the PMP had a negative impact on pain
management in their practice. Of 89 individuals that neither agreed nor disagreed that the
PMP was a useful tool for monitoring a patient's controlled-substance history, 9
participants felt their knowledge was good or very good. Lack of knowledge was found
to be the most common response for why the participants did not seek access to the PMP.
In summary. Gershman et al. (2014) revealed most participants believed the PMP was a
useful tool for monitoring a patient's controlled-substance history and more continuing
education programs should be provided to Florida physicians to enhance their knowledge
regarding PMPs. Also, 82% of physicians who were actively using the system strongly
agreed they have prescribed fewer controlled substances since accessing the PMP.
Clinician Use of PMP
Flildebran, Cohen, Irvine, Foley. O'Kane, Beran, and Deyo (2014) conducted a
study for the purpose of identifying ways in which PMPs were incorporated into
workflow and clinical decision-making, barriers faced with PMPs, and sharing practices
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of clinicians with their patients. The significance of their study was to determine the
utilization practices and barriers associated with the PMP in identifying potential
controlled drug misuse, diversion, or excessive prescribing. Hildenbran et al. (2014)
aimed to evaluate three different aspects of the PMP. Their interests included how
clinicians use PMP data in clinical decision-making, how they integrate data into clinical
workflow, and how they perceive the PMP systems.
Hildenbran et al. (2014) research focused on clinicians but was not limited to one
specific type of setting. Various practice settings included pain management, emergency
and family medicine, psychiatry/behavioral health, rehabilitation medicine, internal
medicine, and dentistry. The population included 35 clinicians from nine states.
Hildenbran et al. (2014) found clinicians described using the PMP mainly for clinical
purposes. Plowever. at times, it was also reported as used for administrative puiposes to
ensure no prescription falsification. Clinical uses of the PMP included verifying current
prescriptions or fill history. Participants also reported utilizing the PMP to coordinate
care with other clinicians. Results concerning how the PMP was integrated into
workflow varied. In settings where substance abuse issues and opioid treatment was
common (e.g., psychiatry and pain clinics), clinicians described a consistent and rigorous
process for using the PMP. Settings with episodic treatment with opioids resulted in a
reported decrease in frequency and utilization of the PMP. The sharing of PMP
information with patients varied as well. Clinicians reported discussing PMP data with
patients in attempts to understand the information and utilize it as an opportunity to
address existing and/or potential issues with substance use. Clinicians also reported
completely avoiding discussion of findings with patients to defer confrontation.
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Hildenbran et al. (2014) detailed importance of the PMPs and how it affected the
prescribing of opioids in clinical practice.

Opioid Diversion
McDonald and Carlson (2013) conducted a study focused on increases in opioid
overdose and misuse in the United States. The purpose of their study was to
acknowledge the opioid epidemic and estimate the incidence of individuals who were
prescribed narcotic pain medications, particularly focusing on those who acquired such
prescriptions from multiple medical providers. The background of their study discussed
how there currently are "no national estimates of diversion by doctor shopping in the
published literature" (McDonald & Carlson, p. 1). McDonald and Carlson (2013)
discussed that most narcotic medications are acquired via prescriptions in the United
States written by healthcare providers. According to McDonald and Carlson (2013),
unfortunately many healthcare providers did not have access to universal electronic
medical records, and, therefore, they rely on information strictly from the patient
regarding what treatments/medications they have or have not received. The significance
of their study, and an obvious concern in healthcare today, was whether patients were
truthful regarding prior controlled substance prescriptions, particularly when patients
sought medical care from multiple providers. McDonald and Carlson (2013) sought to
determine the frequency of opioid misuse via doctor shopping of patients by examining
the following: 1) Doctor shopping in the year 2008 (as evidenced by filling multiple
prescriptions for opioids by multiple prescribers), 2) Factors of specific age groups, 3)
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Patients seeking to utilize certain payment methods, 4) Volume of narcotic prescriptions,
and 5) Type of narcotic medications and how such factors are related to doctor shopping.
The study by McDonald and Carlson (2013) was conducted by review of
prescription medication records. The setting was the United States, as a nationwide
sample was taken from retail pharmacies throughout the country through a large
healthcare agency based in Virginia. The population was comprised of 13.6 million
patients that had received prescriptions for narcotic medications in the year 2008. Three
different categories of pharmacies were sampled, chain, independent, or other.
The statistical findings included percentages of patients during January and
February 2008 who were actively purchasing opioid pain medication, noting 43% of
these patients purchased no further opioid prescriptions for the remainder of 2008. Of the
57% of patients that did have further opioid prescription activity, 14% of those utilized
two different prescribers. "Three percent obtained prescriptions from 5-9 prescribers,
0.35% from 10-19, and 0.04% from 20 or more" (McDonald and Carlson, p. 4). They
derived that based on their data, out of the 19 million individuals included in their study,
approximately 0.7% could be considered in an extreme categorization, or a category of
high likelihood of opioid abuse based upon prescription habits for the specified time
period. Oxycodone was identified as the most likely medication to be abused based upon
their findings.

The extreme risk subsets of patients, "purchased enough opioids to

provide a very high daily dosage (109 morphine equivalent milligrams) for all 365 days
that year" (McDonald and Carlson, p. 6). Those statistics have implications to the
science of nursing and medicine, as they have helped identify a better picture of the
opioid crisis within our country. Those findings can help guide nurse practitioners and
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physicians alike in the choice of whether to prescribe narcotic pain medications.
Although all doctor shoppers may not readily be identified, the research by McDonald
and Carlson (2013) gave a picture of the prevalence of such and highlighted concerns
providers should have when considering such medications.
I he prevalence of doctor shopping was addressed, and it provided a strong
foundation for our research by providing pertinent data as to frequency of doctor
shopping within the United States. Although there was not a theoretical concept tested in
McDonald and Carlson's (2013) study, it does pose a recommendation for future research
regarding use of prescription monitoring programs and effectiveness of this in
recognizing patients that may be misusing prescription medications.

Summary
The review of literature performed emphasized the importance of the research in
determining effectiveness of the PMP and usefulness it poises in combating the opioid
epidemic. The literature reviewed provided foundational information that indicated
PMPs can be a very valuable tool for the nurse practitioner. Dormuth et al. (2012)
studied opioid prescriptions before and after implementation of the PMP and found a
significant decrease in quantity of prescriptions after implementation of the PMP.
Rutkow et al. (2017) noted providers could benefit from easier access and availability of
a PMP. Irvine et al. (2014) found physicians who had training in pain management
utilized the PMP more than those who did not. McDonald and Carlson (2013) found it
easier for providers to determine patterns of doctor shopping when they used the PMP.
McCall et al. (2013) also noted the decrease in doctor and dispensary shopping with the
utilization of the PMP. Hildenbran et al. (2014) noted provider use of PMP varies greatly
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according to clinical setting. Gershman et al. (2014) identified that most providers see a
great benefit in using the PMP and feel if patients knew the provider reviewed the PMP
the patient's misuse of prescriptions would decrease. Lin et al. (2016) found providers
were more comfortable prescribing opioids when they utilized the PMP. Overall, the
literature review showed that utilization of the PMP positively affected controlled
substance use. However, discrepancies were identified in regard to clinic settings and
accessibility. These findings highlighted the need for intervention measures.
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CHAPTER III
Methodology
Ihe purpose of this study was to determine if nurse practitioners in Mississippi
are utilizing the PMP appropriately in order to reduce controlled substance abuse. Opioid
overdose deaths have increased exponentially in the last three decades and opioid
prescribing practices have become an exceptional interest of concern. Mississippi ranks
as one of the highest states in the nation in regard to opioid prescriptions (Mississippi
State Department of Health. 2016). Therefore, the researchers evaluated opioid
prescribing practices in Mississippi to determine the most current utilization of the
Mississippi PMP. This body of research first detailed two important components
associated with the reduction of opioid prescriptions: (a) Mississippi nurse practitioners'
utilization practices of the PMP, and (b) Mississippi nurse practitioners' opioid
prescribing practices. The secondary focus of the research was determining best practices
of PMP use for the monitoring of controlled substance abuse and risk reduction.
Evaluations of PMPs has shown promising state-level interventions to improve opioid
prescribing, informative clinical practice, and protect patients at risk (CDC, 2016).
Finally, the researchers examined any need for improvement concerning usage and
accessibility of the PMP. The student researchers assumed that through proper utilization
of the PMP. a subsequent reduction of opioid prescriptions would be observed. The
remainder of this chapter will focus on the structure and methods used for implicating the
study.
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Design of the Study
A quantitative non-experimental design was used for this research study through a
survey approach. 1he online survey was conducted through Survey Monkey in the form
of a questionnaire. Participants who participated in the survey were given 13 questions to
address. This design was appropriate, because data were collected to quantify a problem
and understand how prevalent that problem is by looking for projectable results within a
larger population. More specifically, the researchers quantified the practices of
prescription writing by nurse practitioners in the state of Mississippi and the resultant
controlled substance abuse and misuse. A 13-question survey was constructed and made
available to nurse practitioners in the state of Mississippi. Questions included in the
survey addressed utilization practices of the PMP and prescribing practices of opioids.
Specifically, the questions addressed ease of accessibility and utility of the PMP.
Participants were also questioned regarding how the PMP affected their prescribing
practices. The survey's purpose was to determine if use of the PMP directly reduced
opioid prescriptions and if it prompted evaluation for substance misuse.
Setting
The setting for the research project was primary care clinics in the state of
Mississippi. More specifically, the researchers collected data from many rural, private,
and chain owned clinics in Mississippi in which nurse practitioners were staffed. Surveys
were sent to APRN groups whom were accessed via social media. Additional
practitioners that served as preceptors for the researchers were also provided with survey
accessibility. Data were collected from clinics in rural and urban areas throughout
Mississippi. Data were obtained from a questionnaire that was emailed to primary care
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nurse practitioners in Mississippi via www.surveymonkey.com. The questionnaire was
posted on social media and data were collected from those responses. The researchers
personally delivered the questionnaire link to a few clinics where they personally knew
the primary care nurse practitioners and believed they could obtain a response.
Sample and Population
The target population for this study was nurse practitioners in the state of
Mississippi that prescribe controlled substances within a primary care setting. The
accessible population for this study was nurse practitioners in Mississippi that met the
criteria and could be reached via social media, email, or a personal acquaintance of one
of the researchers. The specific criteria required for survey participation were: 1) Must
be a nurse practitioner in the state of Mississippi, 2) Prescribes controlled substances and
3) Works as a primary care nurse practitioner. Nurse practitioners were chosen as the
focus group for the study because as nurse practitioner students, the researchers wanted to
survey their future peers located in the same geographical area. Also, as nurse
practitioner students, the researchers felt like they would receive a better response rate
from nurse practitioners as opposed to physicians. A random convenience sample
consisted of 1) 100 surveys sent by email to addresses obtained from the school secretary,
2) 10 surveys that were personally delivered by the researchers, and 3) As many nurse
practitioners that were active social media users. I he researchers desired to have a
minimum response rate of 60 participants.
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Methods of Data Collection
I he main method of data collection planned for this study was a survey conducted
by the researchers. The researchers obtained IRB approval. The survey was submitted to
nurse practitioners in Mississippi using closed ended questions primarily with yes or no
answers and no more than 3 answer choices. The surveys were collected over a onemonth period. The survey was distributed via social media and a mass email listing
retrieved from the graduate nursing department secretary. The survey was conducted
using Survey Monkey, and the various answers were compiled to gain insight as to
whether nurse practitioners were using the prescription monitoring program for health
promotion of their patients. The survey was 13 questions in length and was anticipated to
take 2-5 minutes to complete. The questions utilized in the survey are located in
Appendix A.
Methods of Data Analysis
The following steps were used for data processing and analysis. First, the
researchers gathered the surveys returned from Survey Monkey. The researchers then
compiled a document summarizing the frequency of specific answers for each question.
For example, the researchers listed question number and subsequently listed the answer
choices of yes and no, followed by the number of nurse practitioners that answered each
of these choices. The researchers evaluated the data to determine if there were any trends
among responses from the nurse practitioners. The researchers also reviewed the surveys
for questions with large variances in responses, such as questions that listed three
possible answer choices and approximately 30% of each answer was selected by the
respondents. A computer program, Survey Monkey, was utilized to compile the data.
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Percentages of nurse practitioners that were utilizing the prescription monitoring program
were calculated based upon the responses by a statistician. The data obtained will be
utilized to promote health and well-being of patients who have the potential to be
negatively impacted by controlled substance misuse and abuse.

CHAPTER IV
Results
I he purpose of this research study was to determine whether nurse practitioners in
Mississippi are utilizing the PMP appropriately in order to reduce controlled substance
abuse and ultimately save lives. Clinical practice guidelines encourage use of the PMP
prior to prescribing a controlled substance in an effort to assess a patient's history of
controlled substance use (CDC, 2018). The Mississippi Prescription Monitoring Program
is an electronic tracking program to help practitioners and dispensers identify any
possible inappropriate use of controlled substances. The PMP's mission is to support the
legitimate use of controlled substances while safeguarding public health and safety. A
quantitative design was used for this research study through a survey approach. A survey
was constructed and made available to nurse practitioners in the state of Mississippi,
which aimed to determine if use of the PMP directly influenced opioid prescribing
practices. The survey consisted of 13 multiple choice questions which were related to
controlled substance prescribing and use of the PMP. The survey was created using
Survey Monkey. The survey was distributed via social media on a page directed towards
the interests of nurse practitioners. A general summarization of the participants used in
this study has been documented in this chapter. Also, a summary of the statistical
findings of the survey has been examined in this chapter.
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Profile of Study Participants
A total ol 50 (N = 50) nurse practitioners completed surveys for this study. The
target population was primary care nurse practitioners within the state of Mississippi.
According to the survey, the majority of 50 respondents had active DEA licenses,
prescribed controlled substances, and had been practicing less than 5 years. Figures 1
and 2 represent the statistical composition of the profile of participants.

Are you a nurse practitioner in the state of Mississippi with active DEA licensure/number?
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Are you a nurse practitioner in the state of Mississippi with active DEA licensure/number?

Figure 1 Nurse practitioners with an active DEA.
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How long have you been a nurse practitioner?
60

50

40 |

C=
<L>
U
0)

Q-

30

20

10

0

less than 5yrs

5-10 yrs

more than 10 yrs
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Figure 2. Y e a r s i n p r a c t i c e .

Findings

The survey results from 50 participants (N = 50) were downloaded from Survey
Monkey and provided to a statistician service who analyzed the survey question
responses, tallied each response and calculated the percentages of each response. The
majority, 96% (n = 48) of nurse practitioners who responded to the survey indicated they
hold an active DEA license. Length of years in practice as a nurse practitioner was
measured in three increments; less than 5 years of experience, 5 to 10 years ot experience
and more than 10 years of experience. Respondents with less than 5 years of experience
were the majority at 56% (n = 28). Practitioners with 5 to 10 years of experience made
up 32% (n = 16) of participants and practitioners with more than 10 years of experience
accounted for the lowest number of participants with 12% (n = 6) participating.
Practitioners were asked to respond regarding the frequency of utilization of the
PMP before prescribing opioids or controlled substances. Ninety-two percent (il = 46)
responded that they always check the PMP, 2% (n = 1) responded that they never check
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the PMP. and 6% (n = 3) said they sometimes check the PMP before prescribing opioids
or controlled substances. Practitioners were asked if they believed the PMP was easily
accessible and user friendly. Ninety-four percent (n = 47) responded that they found the
PMP easily accessible and user friendly, while 6% (n = 3) disagreed and did not find the
PMP easily accessible and user friendly.
Survey participants were asked if they screened patients for substance abuse after
concerning findings on the patient's PMP. Thirty-eight participants responded ''yes they
do screen their patients, 7 participants responded "no", 4 participants responded that they
"sometimes" screen their patients and 1 participant's response was missing from the
survey results. Participants responded that 26% (n = 13) referred patients for substance
misuse based on their PMP review and 74% (n = 37) responded that they have not
referred patients based on PMP review. When asked if participants have ever denied a
prescription for a patient based on review of the PMP. 43 participants responded they
have denied a prescription to a patient and 7 participants responded that they have not
denied a prescription to a patient.
When asked if the information found in the patient's PMP would influence the
provider's decision as to whether or not to prescribe a contioiled substance, 90/o (n
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responded "yes", 2% (n = 1) responded "no", and 8% (n = 4) responded "sometimes".
Participants were asked if they have ever terminated a patient/provider relationship due to
findings on the patient's PMP, such as multiple prescribers. The respondents indicated
that 30% (n = 15) have terminated a patient/provider relationship while 70% (n = 35)
have not terminated a patient/provider relationship based on findings from the PMP. Six
participants answered they prescribe opioids in conjunction with benzodiazepines. Forty

participants answeied they do not prescribe opioids in conjunction with benzodiazepines,
while 4 participants responded they sometimes prescribe opioids in conjunction with
benzodiazepines.
Ninety-eight percent (n = 49) of respondents personally access the PMP and 2%
ot respondents use a delegate to access the PMP. Twenty-nine participants responded
their facility has a quality assurance program or a quarterly review of its prescribing
practices, while 20 participants say their facility does not have a quality assurance
program or a quarterly review, and 1 participant response was missing from the results.
Lastly, participants were asked if they believe proper use of the prescription
monitoring program can help decrease controlled substance abuse. Figure 10 illustrates
the results of the survey question.

Do you believe proper use of the prescription monitoring
program can help decrease controlled substance abuse?
Cumulative
Percent

Frequency

Valid Percent

Percent

44

88.0

88.0

88.0

No

2

4.0

4.0

92.0

Sometimes

4

8.0

8.0

100.0

50

100.0

100.0

Yes

Total

Figure 10. PMP decrease controlled substance abuse.
Statistical Results

The survey questions and results addressed the two research questions proposed:
1. Do primary care providers in Mississippi utilize the prescription monitoring
program for patients before prescribing or refilling controlled substances?
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2. Has use of the prescription monitoring program reduced the number of
prescriptions for controlled substances that primary care providers prescribe?
The results support an affirmative response to question one. According to the survey
response, 92% of providers reported they check the PMP prior to writing a prescription
for opioids or controlled substances. Most of the providers (98%) responded they
personally access the PMP rather than using a delegate to review the PMP.
The second question was not directly addressed by the survey. However, the vast
majority of respondents (89.1%) reported they believe that the use of the PMP can help
decrease the problem of controlled substance abuse. Eighty-six percent of the survey
participants reported they have at some time, during their practice, denied a prescription
for a patient base on review of the PMP. The survey findings lead to the assumption that
the PMP likely reduced the number of prescriptions for controlled substances that
primary care providers prescribe. However, since the second question was not directly
addressed in the survey, we were unable to determine with certainty that the PMP has
reduced the number of prescriptions for controlled substances that primary care providers
prescribe.

Summary
In conclusion, the findings of the study indicate that the majority of nurse
practitioners in Mississippi are utilizing the PMP prior to the prescribing of controlled
substances. The study highlighted that the majority of nurse practitioners in Mississippi
are utilizing the PMP frequently. The study also highlighted that the majority of nurse
practitioners in Mississippi are not referring patients for substance abuse issues related to
the findings on the PMP. The survey noted that the majority of those who provided
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survey responses had been nurse practitioners for less than 5 years, which indicated to the
reseaicheis that results could have possibly been skewed differently had additional
responses have been received from more experienced nurse practitioners. Overall, the
PMP appeared to have an effect on the prescribing practices of controlled substances by
nurse practitioners in Mississippi.

CHAPTER V
Introduction
Overdose deaths by prescription opioids is a growing problem in the United
States. Casual prescribing practices of controlled substances is a major factor in patient
addiction leading to the United States opioid epidemic. Mississippi's rate of opioid
prescriptions is one ol the highest in the nation (Mississippi State Department of Health,
2016). The United States passed legislation to decrease high-risk prescribing practices
through the Prescription Monitoring Program (PMP). A prescription drug-monitoring
program is an electronic database that tracks controlled substance prescriptions in a state
(CDC, 2018). The Mississippi Prescription Monitoring Program is managed by the
Mississippi Board of Pharmacy to aid practitioners and dispensers in providing proper
pharmaceutical care related to controlled substances. Clinical practice guidelines
encourage use of the PMP prior to prescribing to review a patient's history of controlled
substance use.
The purpose of this study was to assess nurse practitioners' utilization of the PMP
and examine their opioid practices within the state of Mississippi. Examination of these
two areas may reveal ways in which Mississippi's controlled substance prescribing
practices, and the monitoring of them could yield areas for improvement. Literature was
reviewed as a guide for this research. Discussion among the researchers focused on
assumptions and limitations, d he researchers used their ideas to determine the most
efficient means to gather the responses required, in order to provide evidence to support
the impact nurse practitioner prescribing practices have on the opioid epidemic, and
ultimately help educate on ways to decrease opioid-related overdoses and deaths.
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A 13-question survey using a quantitative non-experimental design was created
and distributed to nurse practitioners in Mississippi via email, social media, and hand
delivery. Fifty responses were collected from the survey, which was less than the
researchers had anticipated. However, the data was analyzed, and statistics were created
based on these responses. The majority of the participants reported using the Prescription
Monitoring Program prior to writing prescriptions for controlled substances and making
decisions on whether or not to continue to prescribe these categories of medications
based on the information the program provided. The majority reported they are not
referring patients for substance abuse treatment based upon the findings of the PMP.
Most respondents report utilizing the Prescription Monitoring Program appropriately by
accessing the PMP before prescribing opioids. This study indicated that using the PMP
has reduced the number of opioids prescribed. The PMP appeared effective in
controlling the amount of controlled substance prescriptions. Substance abusers usually
need treatment to assist them in ceasing use of controlled substances, and it seems that
nurse practitioners in Mississippi are not adequately acknowledging or referring these
patients.
The research team acknowledge that there is a problem in Mississippi related to
overdose deaths by prescription opioids. The team sought to investigate prescribing
practices among nurse practitioners in Mississippi in an effort to uncover ways to
improve inappropriate prescribing and reduce the number of deaths related to these
medications. This chapter contains full details of the following areas: 1) Purpose of the
research project, 2) Summary of the study findings, 3) Discussion of the study findings,
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4) Limitation of the study, 5) Conclusions oi the stud)', 6) Implications of the study, 7)
and recommendations for future studies.
Summary of the Findings
I he purpose of this study was to examine the utilization of the PMP by
Mississippi nurse practitioners and whether it affected opioid or controlled substance
prescribing practices. The majority of the participants in this study answered that they do
check the PMP prior to prescribing opioids or controlled substances. This indicates that
before they prescribe a controlled substance, they look at that patient's PMP profile to
determine whether the patient has had any other controlled substance prescriptions filled.
The majority also answered that the information obtained from the PMP does influence
their decision to prescribe. The nurse practitioner reviews the PMP profile and
determines whether or not they should prescribe controlled substances based on the
findings. Less than half of the respondents indicated that they have terminated a patient
relationship based on PMP findings. A large majority of participants indicated that they
have previously denied a controlled substance prescription to a patient. The majority of
participants believed that usage of the PMP can help decrease controlled substance abuse.
Their response was of particular importance because it revealed that the majority of nurse
practitioners utilize the PMP and believe the PMP can help reduce overall prescription
opioid abuse.
Discussion of the Findings
Rutkow et al. (2017) aimed to identify obstacles or barriers to ease of use of the
PMP for providers. Rutkow et al. (2017) identified that compliance with provider use of
the PMP was greatly increased when the provider felt the PMP was easy to access and
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user friendly. Our research identified that practitioners in Mississippi feel that the PMP is
easily accessible and user friendly. Our findings support the findings of Gershman et al.
(2014), which found that the majority of prescribers felt the PMP was a useful tool for the
reduction of controlled substance prescriptions and that ease of use was a positive
characteristic.
Donnuth et al. (2012) researched the volume of inappropriate prescription drugs
before and after the implementation of a PMP and found the PMP significantly reduced
the volume of prescription drugs being abused. Dormuth et al. (2012) indicated that the
PMP is a valuable tool. Our survey results complimented those of Dormuth et al. (2012)
with the majority of survey participants responding they have denied a prescription for a
patient based on review of their PMP.
Lin et al. (2016) also performed a survey with similar questions to our survey.
The results from the survey of Lin et al. (2016) indicated that physicians were more
comfortable with their prescribing habits with the use of the PMP. The physicians also
responded that the PMP reduced the amount of prescriptions for controlled substances
they issued. Once again, their results coincided with our results.
lrvin et al. (2014) found that the majority of prescribers would discuss concerning
findings on the PMP with their patients and most would make referrals to mental health
providers based on their findings.

Our survey results also align with the majority of

participants stating they would screen their patient for substance abuse after concerning
findings on their PMP; however, the majority of our respondents indicated that they have
never referred a patient for substance misuse based on their PMP review. This response
from Mississippi nurse practitioners likely indicated the need for further education and
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the need foi more readily available mental health and substance abuse centers in
Mississippi. Ilildebian et al. (2014) found varying results with some prescribers
reporting they would discuss the findings ol the PMP with their patients and other
providers repotting they would avoid the confrontational discussion.
I he majority of the literature that was reviewed in the building of this study was
congruent with the outcomes we received from the survey and answering of our research
questions. Outcomes noted that ease of use was a major indicator for utilization of the
PMP. Mississippi recently mandated that nurse practitioners access the PMP, which is
likely why 92% of our participants responded that they check the PMP prior to writing a
prescription for opioids or controlled substances. Most of the literature reviewed did not
indicate whether PMP use was mandatory or not.
Slightly more than half of the participants indicated they have a quality assurance
program or quarterly review of prescribing practices. None of the literature reviewed
addressed quality indicators or review practices. The results of the survey indicated the
need for more education of best practices and the need for possibly a mandated
educational requirement to ensure consistency throughout the state.
Limitations
1. Non-participation by recipients
First, as with any research project, the survey was subject to potential nonresponse. Although the survey was distributed to a list of e-mail address belonging to
primary care nurse practitioners in Mississippi, there were some persons who chose not to
participate. It is possible that some of the email addresses may have no longer been
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active accounts, person(s) may not have checked their email during the time of the
survey, or lack ol time and or interest may have caused them to disregard the survey.
2. Small sample size
A second limitation of the study was the small sample size, which possibly limited
the utility of the findings.

The researchers desired to receive a minimum of 60 survey

responses, however, only 50 responses were received. A larger sample would likely have
produced more reliable data.
3. Social desirability bias
Thirdly, the findings

were subject to social desirability bias. Although steps wrere

taken to minimize the potential of social desirability bias, including non-identifiable
surveys and confidential responses, one can consider that participants may not have been
honest in their responses and answered questions according to what they felt were the
socially acceptable answers.
4. Dishonest responses
Lastly, one must also consider dishonest responses from participants based on the
fact that Mississippi law requires usage of the PMP. and participants may have felt like
they would get reprimanded if they indicated that they were not using the PMP according
to state requirements.

Conclusions
The survey provided many pieces of positive insight to the methods in which
nurse practitioners in the state of Mississippi were utilizing the PMP. Most participants
report use of the PMP prior to prescribing any controlled substance or opioid
prescription; most participants also answered on the questionnaire that they have declined
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to write a prescription lor a controlled substance based upon findings on the PMP. These
responses reveal that nurse practitioners, or at least the respondents to the survey, are
utilizing the PMP accordingly to reduce controlled substance prescribing when not
appropriate. C onsequently, these choices regarding controlled substance prescriptions
have the ability to lessen prescription drug abuse by the patients, lor which these
providers are treating. Based upon the survey responses, many of the respondents,
however, did not refer patients who were found to be abusive of prescription medications
for any type of substance misuse treatment or rehabilitation. Many of these patients may
have difficulty recovering from addiction and/or abuse, and the providers who are not
providing such referrals or at least addressing the need for such appear to be missing a
crucial opportunity to decrease controlled substance abuse.
Implications
Since these findings do confirm that nurse practitioners in Mississippi are
utilizing the PMP appropriately, we feel an implication of these findings is that controlled
substance prescriptions can be decreased by nurse practitioners based upon relevant
information of patient's likelihood of abuse of such a prescription prior to it being
written. However, this implication was based on the nurse practitioner profession as a
whole. While there are many nurse practitioners within pain management settings who
prescribe opioids, our focus was to determine if opioid prescribing in Mississippi bj
primary care nurse practitioners could be decreased. Based on the knowledge provided
by the survey respondents that referrals for substance abuse treatment are not routinely
recommended or discussed, this provided an implication for further education to nurse
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practitioners in Mississippi on the dangers and repercussions of untreated substance
abuse in their patient populations and the importance of such referrals and discussions.

Recom mendations
Two ol the survey participants responded that they were not nurse practitioners in
the state of Mississippi with an active DEA licensure number. One recommendation from
our research study would be to compose a similar study but limit the respondents to only
those who hold DEA licensure and can write controlled substance prescriptions. On
many questions related to controlled substances prescribing, 1 -2 participants provided an
answer of No to questions which the vast majority of participants answered Yes, and
these responses of No were likely generated by those who did not hold DEA licensure
and therefore cannot write controlled substance prescriptions. Although, all providers,
regardless DEA licensure status, are required to access the Mississippi PMP, we should
have excluded the survey results of the two participants who responded they did not hold
an active DEA license. Many of the survey questions may have been answered
incorrectly by those two respondents, however, the majority rate and minority rate of the
statistical results received from responses would not have changed if those participants'
responses had been excluded from calculations.

Appendix A
Survey Questions
1. Are you a nuise practitioner in the state of Mississippi with active DEA
licensure/number?
2. How long have you been a nurse practitioner?
j. Do you check the PMP prior to writing a prescription for opioids or controlled
substances?
4. Do you find the PMP to be easily accessible and user friendly?
5. Do you ever screen your patient for substance abuse after concerning findings on
their PMP?
6. Does the information you find on the PMP influence your decision in whether or
not to prescribe a controlled substance?
7. Do you ever prescribe opioids in conjunction with benzodiazepines?
8. Do you personally access the PMP or do you utilize a delegate to access this
information?
9. Does your facility have a quality assurance program or a quarterly review of its
prescribing practices?
10. Do you believe proper use of the prescription monitoring program can help
decrease controlled substance abuse?
11. Have you ever referred a patient for substance misuse based on their PMP review?
12. Have you ever denied a prescription for a patient based on review of their PMP?
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3. Ha\e you ever terminated a patient/provider relationship due to findings on the
patient s PMP, such as multiple prescribers or use of medication in a manner other
than you have prescribed?

Appendix B
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